Tumor uptake (%ID/g; percentage injected dose per gram of organ or tissue) in AB-36, AB-37 and AB-53 groups, but not the AB-39, was significantly higher in the non-blocking group compared to the blocking group, indicating the presence of EGFR expression in those tissues (Fig. 2A and B). The gene discussed is EGFR; the disease is neoplasm.